$XBI $71.09 | +3.83%
Table of Contents:
Covid Updates
$
Pipeline Updates
$INO +13.7% INOVIO Announces Survival Results for INO-5401 + INO-9012 in Combination with Libtayo® (cemiplimab) in Patients with Newly Diagnosed GBM at ASCO Annual Meeting 2022 source
$TIL -24.3% Instil Bio Announces IND Clearance of First CoStAR-TIL program, ITIL-306, Designed to Enhance Activity in the Tumor Microenvironment source
$AMRX -0.9% Amneal Achieves Third U.S. Biosimilar Approval with FYLNETRAâ„¢ (pegfilgrastim-pbbk) source
Â
Want to get weekly catalyst updates?
*We never spam you - unsubscribe anytime*
Â
Business Updates
$
Â
Posted by JM